PVPeter M. Vila

Peter M. Vila

*This is an algorithmically generated author record based on publicly available information.

Peter M. Vila has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patient and Surgeon‐Reported Satisfaction With Reconstruction Following Superficial Parotidectomy: A Systematic Review and Meta‐Analysis

    by Jacob S. Brady, G. Nina Lu, Peter M. Vila, Zain H. Rizvi

    Objectives: (1) Assess current methods for the collection of patient‐ and surgeon‐reported outcomes after superficial parotidectomy reconstruction. (2) Determine which post‐parotidectomy reconstructive method provides the highest degree of patient satisfaction.Methods: PRISMA guidelines were followed for article identification and selection. A total of 17 peer‐reviewed articles including 898 patients were included in the study. Outcome data was mathematically harmonized across studies to allow statistical analysis. Random effects meta‐analysis of proportions was performed. The Freeman‐Tukey Double Arcsine method was used to calculate the pooled estimate, or rate for each analyzed outcome.Results: No standardized or previously validated instrument was used to collect patient satisfaction data following superficial parotidectomy reconstruction in any of the included studies. After data harmonization, overall patient satisfaction was 93% when no reconstruction was performed, compared to 97% for sternocleidomastoid flap (SCM), and 100% for superficial muscular aponeurotic system flap (SMAS). Patient satisfaction of symmetry was 41% when no reconstruction was performed, compared to 65% for SMAS, 95% for free fat graft, and 96% for SCM.Conclusions: Reporting methods for patient satisfaction with appearance and symmetry after superficial parotidectomy and reconstruction are heterogeneous and non‐standardized. Artificially harmonized data demonstrate that patient‐reported outcomes of satisfaction and symmetry were improved following any form of reconstruction after parotidectomy, and patients reported symmetry‐specific satisfaction was less when SMAS reconstruction was performed. Validated and objective instruments should be utilized to determine the optimal approach to facial reconstruction after superficial parotidectomy to maximize patient‐centered outcomes.Level of Evidence: 3.


  • Tourniquet use and factors associated with hematoma formation in free tissue transfer

    by Christopher J. Britt, Michelle S. Hwang, Peter M. Vila, Rajan P. Dang, Shannon I. Fleming, Aman M. Patel, Randal C. Paniello, Jason T. Rich, Matthew M. Hanasono, Shaun C. Desai


  • Rates of sialoendoscopy and sialoadenectomy in 5,111 adults with private insurance

    by Peter M. Vila, Margaret A. Olsen, Jay F. Piccirillo, M. Allison Ogden

    Objective: To determine frequencies and trends in sialoendoscopy and sialoadenectomy for the treatment of obstructive, nonneoplastic submandibular gland disease in the United States.Methods: Epidemiologic study of insurance claims from 2006 to 2013 in a large, private insurance claims database. Rates were calculated for patients undergoing one or both index procedures.Results: A total of 5,111 adults with sialadenitis who underwent sialoendoscopy or submandibular gland excision were included. Mean age was 47.6 years, and patients undergoing sialoendoscopy were less likely to be male (relative risk [RR] = 0.84; 95% confidence interval [CI], 0.78–0.89), more likely to have sialoadenitis without stones (RR = 1.60; 95% CI, 1.53–1.66), and had a similar number of comorbidities (RR = 1.00; 95% CI, 0.91–1.06) compared to patients undergoing sialoadenectomy. The most common complication after sialoadenectomy was surgical site infection (1.4%; 95% CI, 1.1–1.8%), and complications after sialoendoscopy were rare. From 2007 to 2013, use of sialoendoscopy increased from 0.13 (95% CI, 0.08–0.18) to 0.42 (95% CI, 0.40–0.45) per 100 thousand people, and sialoadenectomy decreased from 2.41 (95% CI, 2.39–2.42) to 1.43 (95% CI, 1.40–1.44) per 100 thousand. The highest mean rate of sialadenectomy was seen in the south (2.15 per 100,000; 95% CI, 2.13–2.16), the lowest was in the west (1.6 per 100,000; 95% CI, 1.57–1.62), and it decreased in all regions over time.Conclusion: Utilization of sialoendoscopy has increased over time, and the overall rate of sialoadenectomy is decreasing. Both procedures are safe for treatment of patients with sialadenitis and sialolithiasis. Future research should examine whether availability of sialoendoscopy leads to a decreased rate of sialoadenectomy in patients with salivary gland disease.Level of Evidence: 2c Laryngoscope, 129:602–606, 2019


  • Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta‐analysis

    by Carla V. Valenzuela, James C. Liu, Peter M. Vila, Laura Simon, Michelle Doering, Judith E. C. Lieu

    Objectives: The safety and efficacy of intranasal corticosteroids (INCS) are well established, but there remains apprehension that INCS could lead to systemic side effects, as with oral steroids. The objective of this systematic review was to assess whether the use of INCS lead to increased intraocular pressure (IOP) above 20 mm Hg, glaucoma, or formation of posterior subcapsular cataracts in adult patients with rhinitis.Methods: Two medical librarians searched the published literature for records discussing the use of “nasal steroids” in “rhinitis” and their effect on “intraocular pressure,” “cataracts,” or “glaucoma.”Results: A total of 484 studies were identified, and 10 randomized controlled trials met our inclusion criteria. Meta‐analysis of 2,226 patients revealed that the relative risk of elevated IOP in those who received INCS was 2.24 (95% confidence interval [CI]: 0.68 to 7.34) compared to placebo. The absolute increased incidence of elevated IOP in patients using INCS compared to placebo was 0.8% (95% CI: 0% to 1.6%). There were zero cases of glaucoma in both placebo and INCS groups at 12 months. The absolute increased incidence of developing a posterior subcapsular cataract was 0.02% (95% CI: −0.3% to 0.4%).Conclusions: Use of INCS is not associated with a significant risk of elevating IOP or developing a posterior subcapsular cataract in patients with allergic rhinitis. Presence of glaucoma, however, is the real clinical adverse event of concern. There were zero reported cases of glaucoma at 12 months. Future studies should formally evaluate for glaucoma rather than use IOP measures as a surrogate. Laryngoscope, 129:6–12, 2019


  • Early‐injection laryngoplasty may lower risk of thyroplasty: A systematic review and meta‐analysis

    by Peter M. Vila, Neel K. Bhatt, Randal C. Paniello

    Objective: To determine whether injection laryngoplasty within 6 months following the onset of unilateral vocal fold paralysis (UVFP) decreases the rate of permanent thyroplasty in adults.Data Sources: Search strategies created by a medical librarian were implemented in multiple online research databases.Review Methods: Inclusion and exclusion criteria were designed to capture randomized clinical trials and cohort studies examining adults with UVFP who received injection laryngoplasty early in the course of treatment, within 6 months of onset, or who were observed. The primary outcome was the rate of thyroplasty. The Newcastle‐Ottawa scale was used to assess quality of included cohort studies. Random effects meta‐analysis was used to calculate an overall relative risk (RR). Heterogeneity was evaluated with the I2 statistic.Results: The search strategy resulted in 1,177 studies, of which four cohort studies remained for meta‐analysis after applying inclusion and exclusion criteria. All studies were rated as 9 of 9 on the Newcastle‐Ottawa scale. Meta‐analysis of 275 patients with UVFP revealed that the overall pooled RR of undergoing thyroplasty in those receiving an early injection was 0.25 (95% confidence interval 0.14–0.45) compared to conservative management (late or no injection). The I2 overall was 62.4%.Conclusion: Otolaryngologists should offer injection laryngoplasty to patients with a diagnosis of UVFP within 6 months of diagnosis (recommendation based on grade C evidence with a preponderance of benefit over harm). Laryngoscope, 128:935–940, 2018


  • Defining Quality in Head and Neck Reconstruction

    by Peter M. Vila, Jason T. Rich, Shaun C. Desai

    Microvascular free flap reconstruction has now become the standard of care in the reconstruction of selected head and neck defects. Although uncommon, flap failure is a catastrophic event that results in significant patient morbidity, extended length of hospitalization, and increased cost. However, there is currently no gold standard for measuring the quality of a reconstructive center. Structure and process outcomes have recently been developed, but outcome measures are still lacking. Areas for future research include preoperative nutrition, preoperative flap planning, intraoperative fluid management, appropriate thromboembolism prophylaxis, consistent perioperative antibiotic regimens, skilled ancillary staff, and clear outcome measures for performance measurement.


  • The P Value Problem in Otolaryngology: Shifting to Effect Sizes and Confidence Intervals

    by Peter M. Vila, Melanie Elizabeth Townsend, Neel K. Bhatt, W. Katherine Kao, Parul Sinha, J. Gail Neely

    There is a lack of reporting effect sizes and confidence intervals in the current biomedical literature. The objective of this article is to present a discussion of the recent paradigm shift encouraging the use of reporting effect sizes and confidence intervals. Although P values help to inform us about whether an effect exists due to chance, effect sizes inform us about the magnitude of the effect (clinical significance), and confidence intervals inform us about the range of plausible estimates for the general population mean (precision). Reporting effect sizes and confidence intervals is a necessary addition to the biomedical literature, and these concepts are reviewed in this article.


  • Developing Quality Measures for Adult Cochlear Implant Centers

    by Peter M. Vila, Judith E. C. Lieu, Timothy E. Hullar, Craig A. Buchman

    The study objective was to develop quality measures for adult cochlear implant centers. A modified Delphi design beginning with focus groups of surgeons and audiologists was used, as adapted from the American College of Cardiology / American Heart Association method for creating quality measures. Two academic cochlear implant programs and 1 private program participated. Qualitative focus group analysis yielded 58 candidate measures. An additional 5 candidate measures were added from a systematic review of the literature. After exclusion of pediatric measures, structure measures, and process measures and discussion of details and implications of each measure, 8 measures remained as the preliminary Adult Cochlear Implant Outcome (CI‐OUTCOME) Measure Set. This study provides a preliminary set of measures for evaluating the quality of adult cochlear implant centers, based on input from implant surgeons and audiologists. The next step will be to gather feedback from implant patients.


  • Analysis of Outcome Domains in Adult Cochlear Implantation

    by Peter M. Vila, Timothy E. Hullar, Craig A. Buchman, Judith E. C. Lieu

    Objectives: To determine the breadth of outcome domains used in the reporting of adult cochlear implant surgery for the purpose of registry and quality measure development.Data Sources: Systematic review of randomized controlled trials.Review Methods: In consultation with a medical librarian, search strategies were constructed to identify randomized controlled trials studying adults undergoing cochlear implantation. MEDLINE, EMBASE, Scopus, CINAHL, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, and the Database of Abstracts of Reviews of Effects were searched from database inception to July 2015. Studies were evaluated for level of evidence and risk of bias with the Cochrane Collaboration’s Risk of Bias Tool, and outcome domains were extracted from each study.Results: Of 4473 unique citations found, 8 studies were included in this review. All 8 trials were evidence level 1B. Risk of bias was low in 2 trials and high in the other 6. Reported outcome domains included speech perception in quiet and noise, speech tracking, quality of life, timbre perception, hearing preservation, vestibular function, electrode insertion technique, functional measures, functional imaging, fitting time, and tinnitus.Conclusions: An analysis of randomized controlled trials studying cochlear implantation in adults yielded a wide spectrum of outcome domains. This is the first study to comprehensively describe the breadth of outcome domains in adult cochlear implantation. Validated instruments from these domains could be considered for potential inclusion as quality measures and registry use.